Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1966 2
1968 2
1969 2
1970 2
1971 1
1972 2
1973 2
1976 1
1977 1
1978 2
1979 1
1981 1
1983 3
1984 2
1985 2
1986 2
1988 3
1989 1
1990 1
1992 2
1994 1
1995 2
1996 5
1997 3
1998 5
1999 2
2000 3
2001 1
2002 1
2003 2
2004 2
2005 2
2006 2
2007 1
2008 3
2009 4
2010 6
2011 2
2012 2
2013 3
2014 4
2015 2
2016 4
2017 4
2018 2
2019 3
2020 7
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
Isola J, Mäki M, Hils M, Pasternack R, Viiri K, Dotsenko V, Montonen T, Zimmermann T, Mohrbacher R, Greinwald R, Schuppan D. Isola J, et al. Among authors: pasternack r. Int J Mol Sci. 2023 Jun 28;24(13):10815. doi: 10.3390/ijms241310815. Int J Mol Sci. 2023. PMID: 37445994 Free PMC article. Clinical Trial.
[Diagnostics of chlamydia today].
Pasternack R. Pasternack R. Duodecim. 1998;114(14):1373-4. Duodecim. 1998. PMID: 11552244 Finnish. No abstract available.
Chemistry of terramycin.
REGNA PP, PASTERNACK R, SOLOMONS IA, MURAI K, WAGNER RL, BAVLEY A, HOCHSTEIN FA, GORDON PN, HESS G, TIMRECK AE, BRUNINGS KJ, LAZIER WA. REGNA PP, et al. Among authors: pasternack r. Bull World Health Organ. 1952;6(1-2):123-9. Bull World Health Organ. 1952. PMID: 14954415 Free PMC article. No abstract available.
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis.
Mälkönen T, Nuutinen P, Hallinen T, Soini E, Nissinen R, Wennerstöm C, Rantanen T, Hagman JH, Harvima R, Höök-Nikanne J, Ilves T, Lintu P, Malanin K, Soramäki I, Tasanen K, Teho A, Vähävihu K, Itälinna S, Leinonen P, Sarajärvi P, Huilaja L, Pasternack R. Mälkönen T, et al. Among authors: pasternack r. Acta Derm Venereol. 2022 Jan 18;102:adv00631. doi: 10.2340/actadv.v101.910. Acta Derm Venereol. 2022. PMID: 34904684 Free PMC article.
116 results